116 related articles for article (PubMed ID: 16095170)
1. Circulating concentrations of insulin-like growth factor-1 in dogs with naturally occurring mitral regurgitation.
Pedersen HD; Falk T; Häggström J; Tarnow I; Olsen LH; Kvart C; Nielsen MO
J Vet Intern Med; 2005; 19(4):528-32. PubMed ID: 16095170
[TBL] [Abstract][Full Text] [Related]
2. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
3. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy.
Ware WA; Lund DD; Subieta AR; Schmid PG
J Am Vet Med Assoc; 1990 Dec; 197(11):1475-81. PubMed ID: 2272879
[TBL] [Abstract][Full Text] [Related]
5. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation.
Pedersen HD; Schütt T; Søndergaard R; Qvortrup K; Olsen LH; Kristensen AT
J Vet Intern Med; 2003; 17(2):178-84. PubMed ID: 12683618
[TBL] [Abstract][Full Text] [Related]
7. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
[TBL] [Abstract][Full Text] [Related]
8. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of natriuretic peptides in dogs with mitral valve disease.
Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum cystatin-C and symmetric dimethylarginine concentrations in dogs with heart failure from chronic mitral valvular insufficiency.
Choi BS; Moon HS; Seo SH; Hyun C
J Vet Med Sci; 2017 Jan; 79(1):41-46. PubMed ID: 27725349
[TBL] [Abstract][Full Text] [Related]
12. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
[TBL] [Abstract][Full Text] [Related]
14. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels.
Häggström J; Hansson K; Karlberg BE; Kvart C; Olsson K
Am J Vet Res; 1994 May; 55(5):698-703. PubMed ID: 8067620
[TBL] [Abstract][Full Text] [Related]
16. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
[TBL] [Abstract][Full Text] [Related]
17. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
[TBL] [Abstract][Full Text] [Related]
18. A pilot study investigating circulating trimethylamine N-oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure.
Karlin ET; Rush JE; Freeman LM
J Vet Intern Med; 2019 Jan; 33(1):46-53. PubMed ID: 30511765
[TBL] [Abstract][Full Text] [Related]
19. Iron status in dogs with myxomatous mitral valve disease.
Savarese A; Probo M; Locatelli C; Gazzonis AL; Zanzani SA; Traini G; Vitiello T; Brambilla PG
Pol J Vet Sci; 2018 Sep; 21(3):507-515. PubMed ID: 30468339
[TBL] [Abstract][Full Text] [Related]
20. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
